{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sequence&page=45", "query": { "intervention": "Sequence", "page": 45 }, "page_size": 10 }, "pagination": { "page": 45, "page_size": 10, "total_count": 2515, "total_pages": 252, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sequence&page=46&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sequence&page=44&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T04:03:08.997Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04968925", "title": "Evaluation of Comfort for Two Marketed Daily Disposable Contact Lenses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Visual Acuity" ], "interventions": [ { "name": "ACUVUE Oasys 1-Day", "type": "DEVICE" }, { "name": "Precision 1", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johnson & Johnson Vision Care, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 302, "start_date": "2021-07-12", "completion_date": "2021-10-25", "has_results": true, "last_update_posted_date": "2022-12-22", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 10, "location_summary": "Mission Viejo, California • Maitland, Florida • Orange Park, Florida + 7 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Maitland", "state": "Florida" }, { "city": "Orange Park", "state": "Florida" }, { "city": "Roswell", "state": "Georgia" }, { "city": "Bloomington", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04968925" }, { "nct_id": "NCT07318935", "title": "Effects of Performing Arts on Attention-deficit/Hyperactivity Disorder (ADHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "Dance Exergaming", "type": "BEHAVIORAL" }, { "name": "Stationary Cycling", "type": "BEHAVIORAL" }, { "name": "Music Listening", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Virginia Polytechnic Institute and State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "24 Years", "sex": "ALL", "summary": "18 Years to 24 Years" }, "enrollment_count": 69, "start_date": "2024-05-03", "completion_date": "2025-03-26", "has_results": false, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 1, "location_summary": "Blacksburg, Virginia", "locations": [ { "city": "Blacksburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07318935" }, { "nct_id": "NCT04442724", "title": "Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder Cancer", "Urinary Bladder Neoplasm", "Urologic Neoplasms", "Neoplasms", "Urinary Bladder Diseases" ], "interventions": [ { "name": "Fiducial marker placement", "type": "PROCEDURE" }, { "name": "Multiparametric MRI (mpMRI)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "PROCEDURE", "DIAGNOSTIC_TEST" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2020-07-01", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 3, "location_summary": "Los Angeles, California • Boston, Massachusetts", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04442724" }, { "nct_id": "NCT05602597", "title": "HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Relapsed or Refractory Lymphoma" ], "interventions": [ { "name": "Itraconazole 200 mg", "type": "DRUG" }, { "name": "Fluconazole 400 mg", "type": "DRUG" }, { "name": "Rifampin 600 mg", "type": "DRUG" }, { "name": "Rabeprazole 40 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hutchmed", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 59, "start_date": "2022-06-01", "completion_date": "2022-08-06", "has_results": false, "last_update_posted_date": "2024-03-06", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05602597" }, { "nct_id": "NCT01171313", "title": "A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "XP21279 and carbidopa (experimental)", "type": "DRUG" }, { "name": "Sinemet (comparator)", "type": "DRUG" }, { "name": "Placebo for XP21279 and carbidopa", "type": "DRUG" }, { "name": "Placebo for Sinemet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "30 Years to 80 Years" }, "enrollment_count": 35, "start_date": "2010-07", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 12, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Long Beach, California + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Sunnyvale", "state": "California" }, { "city": "Naples", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01171313" }, { "nct_id": "NCT03122223", "title": "Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "ALVAC-HIV (vCP2438)", "type": "BIOLOGICAL" }, { "name": "Bivalent subtype C gp120/MF59", "type": "BIOLOGICAL" }, { "name": "Bivalent subtype C gp120/AS01(B)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 160, "start_date": "2018-01-16", "completion_date": "2020-07-30", "has_results": true, "last_update_posted_date": "2023-03-14", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 9, "location_summary": "San Francisco, California • Decatur, Georgia • Boston, Massachusetts + 5 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03122223" }, { "nct_id": "NCT03438461", "title": "A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Seltorexant 40 mg", "type": "DRUG" }, { "name": "Seltorexant 20 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 49, "start_date": "2018-02-09", "completion_date": "2018-05-30", "has_results": false, "last_update_posted_date": "2025-04-27", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03438461" }, { "nct_id": "NCT04531241", "title": "Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Visual Acuity" ], "interventions": [ { "name": "ACUVUE® OASYS 1-DAY", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johnson & Johnson Vision Care, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 136, "start_date": "2020-08-05", "completion_date": "2020-09-25", "has_results": true, "last_update_posted_date": "2021-12-14", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 7, "location_summary": "Jacksonville, Florida • Maitland, Florida • Tallahassee, Florida + 4 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Tallahassee", "state": "Florida" }, { "city": "Bloomington", "state": "Illinois" }, { "city": "Granville", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04531241" }, { "nct_id": "NCT00898053", "title": "Study of Tumor Samples From Patients With Ewing Sarcoma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor" ], "interventions": [ { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "50 Years", "sex": "ALL", "summary": "Up to 50 Years" }, "enrollment_count": 200, "start_date": "2008-09", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-05-17", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 1, "location_summary": "Monrovia, California", "locations": [ { "city": "Monrovia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00898053" }, { "nct_id": "NCT04925453", "title": "tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Concussion", "Brain Trauma", "Attention Concentration Difficulty", "Brain Injuries", "Brain Injuries, Traumatic", "Neurocognitive Dysfunction", "Attention Impaired", "Memory Impairment", "Mild Traumatic Brain Injury", "Mild Cognitive Impairment" ], "interventions": [ { "name": "active tDCS and cognitive training intervention", "type": "COMBINATION_PRODUCT" }, { "name": "sham tDCS and cognitive training intervention", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "United States Naval Medical Center, San Diego", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 56, "start_date": "2021-01-19", "completion_date": "2025-07-30", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-11-12T04:03:08.997Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04925453" } ] }